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Preliminaries to Treatment Recommendations in UK Primary Care: A Vehicle for
Shared Decision Making?
Rebecca K. Barnes
School of Social and Community Medicine, University of Bristol
ABSTRACT
This paper focuses on a recurrent practice observed in UK primary care data – how physicians use pre-
recommendations: action sequences that when initiated post-diagnosis are recognisably preliminary to
the drug treatment recommendations that they contingently project. Data are drawn from recorded
primary care consultations collected in England. Pre-recommendations consist of physician requests for
information about prior medicines such as, What’ve you tried taking? or Have you taken anything so far?
Patient responses subsequently shape the first part of the base treatment recommendation pair. These
preliminaries can help physicians manage potential obstacles to patient acceptance: by avoiding
prescribing something a patient is already taking, or has tried and found to be ineffective, and by
accommodating concerns such as side effects or practical barriers to acceptance. Pre-recommendations
are a strategy for convincing/persuading whilst allowing physicians to avoid making an ill-fitted
recommendation that might be resisted or rejected as unwanted or unnecessary.
Byrne and Long (1976) described the treatment phase of the
UK primary care medical encounter thus:
This phase may well be a long verbal set of instructions to take
certain pills and do certain things, or it may be a completely
non-verbal, instant tearing-off of a sheet of paper from the
prescription pad with the terse message, “Take this to the
chemist”. (p. 27).
Although these days a flurry of typing followed by the
sound of the printer whirring into action before a prescrip-
tion is signed and handed to the patient might be more
familiar, little else has changed. The majority of patients
still attend primary care for the purpose of obtaining some
kind of medical intervention, and physicians still recom-
mend medical treatments in a range of ways (cf. Stivers
et al., 2017).
Medicines are the commonest treatment used by phy-
sicians to help maintain health, prevent illness, manage
chronic conditions, and treat disease. In 2016, 1.10 billion
prescriptions were dispensed in the community in
England (NHS Digital, 2017). However, evidence has sug-
gested that medicines use in the UK is sub-optimal. This
has resulted in policy campaigns oriented towards improv-
ing outcomes by ensuring that the right patients get the
right choice of medicine, at the right time, thereby avoid-
ing unnecessary medicines, reducing waste, and improving
medicines safety and adherence to treatment (Royal
Pharmaceutical Society, 2013).
Understanding how new medicines get started may
provide some insight into optimising their use. For
example, despite non-adherence often being cast as sitting
squarely within the patient’s domain, some studies have
explored potential associations between adherence and
what happens during the medical visit itself. For instance,
patients’ responses to physicians’ directives have been
found to be a predictor of adherence to medical advice
(Carter, Beach, Inui, Kirscht, & Prodzinsky, 1986; West,
1990). And physician communication practices have also
been shown to play an important role in supporting
adherence (Tarn et al., 2006).
Facilitating patient involvement in decisions to prescribe is
held as a cornerstone of good medical practice in UK policy
guidance (NICE, 2009). Yet how involved are patients in treat-
ment decision making? Before adherence is even an issue, phy-
sicians and patients must arrive at a decision about what
treatment, if any, might be necessary. It is known from previous
research that acceptance is the normative response to a drug
treatment recommendation and that physicians will pursue this
when it is not forthcoming (Stivers, 2005). This paper considers
the advance work that UK physicians can do in environments
where they might reasonably anticipate a need to proceed with
caution, to help ensure an optimal outcome (i.e. that the right
recommendation for this patient might be favourably received).
Patients are not tabulae rasae; they come with experien-
tial knowledge of a range of medical conditions, over-the-
counter (OTC) and prescribed drug treatments, plus knowl-
edge from other sources that inform their beliefs and pre-
ferences. In the context of UK primary care, there are a
number of immediate obstacles to patient acceptance that a
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less cautious approach to prescribing (i.e. with little patient
involvement) might encounter.
Redundancy: In (1), the physician has recommended a treat-
ment the patient is already taking:
(1) 0503801
1 DOC: I would suggest that you just have
2 plenty of fluids, (0.4) u:m,
3 take some pain relief, (0.3) u:m,
4 (0.4) something like Nurofen,
5 (0.4) and alternate it with
6 Paracetamol is quite (.) useful as a
7 (.) pain control.
((7 lines not shown))
14 PAT: Cos=I have been taking (0.6) um, (0.6)
15 Nurofen?
Efficacy: In (2), the physician has recommended a treatment
the patient has previously tried and found to be ineffective.
(2) 09141301
1 DOC: If ↑you had a sort’ov you know
2 a: u:::h u:h a: sort’ov stocking on
3 there (.) >d’you think that w’d< or a
4 little ba:n[dage on there,
5 PAT: [We::ll.
6 DOC: d’you think that w’d make it better or
7 worse.
8 PAT: Well I’ve ↑got stockings, I’ve tried
9 them,
10 DOC: Yeah.
11 PAT: They didn’t do any go:od.
Aversion: In (3), the physician has recommended a treatment,
and in response the patient expresses aversion to taking
‘tablets’. Aversion can include medicines in general, a parti-
cular class of medicines (e.g. painkillers), or medicines asso-
ciated with negative personal experiences or social stigma
(e.g. antidepressants).
(3) 02010602
1 DOC: An we ↑mentioned la:st time about usi:
2 ng uhm some the equivalent of
3 Viagra,
4 PAT: Yeah=I know you told me before_
5 DOC: Ye:ah. .h D’you want to try ↑that?
6 (0.7)
7 PAT: Not really_ >I don’t want to go on
8 tablets all the time<.
Potential for harm: In (4), the physician has recommended
a medicine that the patient expresses concern about in
terms of possible side effects. Other examples include
recommending medicines that patients may be allergic
to, or that would exacerbate, or be contraindicated with
regard to other current medications or conditions (e.g.
non-steroidal anti-inflammatories and asthma).
(4) 05060901
1 DOC: >So what I’m gonna do is I’m gonna
2 prescribe you< some co-codamol
3 >which has got< codeine and paracetamol
4 in it for the pain_
5 (0.3)
6 PAT: Will that hurt me?
7 DOC: ↑Shouldn’t do?
Affordability: In (5), the physician has recommended a treat-
ment, the patient implies that he is not currently able to afford.
(5) 02022007
1 DOC: >An if< you: would like to: try some
2 medication to help with that pain
3 tuh s:ort’ov relax that bowel .hh
4 uhm an stop the spasm you’re
5 welcome to try that.
6 PAT: How much are the prescriptions
7 for [the:
8 DOC: [.Hh the prescriptions you:
9 are at the moment ehm .h >they’re
10 [about seven sixty I think
11 PAT: [°Okay.°
12 DOC: >unless it has gone up< [recently.
13 PAT: [I ↑I’ll give
14 that a miss for now I think.
Patients may not always disclose such obstacles, particu-
larly in the face of a treatment recommendation from their
physician where acceptance is the normative response. This
paper takes on the task of exploring physician practices
designed to manage potential obstacles to prescribing; the
contexts in which they might be employed; and any subse-
quent effect these practices may have on how a treatment
recommendation was ultimately delivered and received.
The analysis here draws on Sacks’ (1992) original notion of
‘pre-structures’: “an ‘expansion’ of some pair sequence, where
that pair gets a ‘pre-sequence’ before it” (p. 685), and their
relationship to interactional preferences and cultural norms
(also see Schegloff, 1980, 2007). For example, prior work on
pre-announcements, pre-invitations, and pre-requests has
demonstrated how pre-sequences can be directed to minimising
the possibility of dispreferred outcomes; that the news to be told
is already known, the invitation to be issued will be declined, or
the request cannot be fulfilled. It is the pre-sequence itself that
does the work to test the water and establish the conditions for
proceeding (or not). Schegloff (2007) argues that interactants:
“display an orientation in them to a base adjacency pair which
may subsequently develop” (p. 28), and identifies ‘go-aheads’,
‘blocks’, and ‘hedges’ as different possible classes of response.
A go-ahead advances the prospective base sequence, a block
can discourage the prospective base, and a hedge can delay pro-
gress contingent on further information. See (6) below for an
example of a pre-invitation sequence in ordinary conversation
that is recognisably preliminary, for the interactants, to the delivery
of a next action.
2 R. K. BARNES
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(6) JG CN:1 (Terasaki, 2004, p.195)
1 A: Whatcha doin’.
2 B: Not much.
3 A: Y’wanna drink?
The enquiry at line 1 enables A to ‘test the water’ before
launching an invitation (here done at line 3). The invitation is
thus contingent on receiving a go-ahead response from B,
which is present in line 2.
This paper investigates the use of pre-sequences in a dif-
ferent context: (i) how physician enquiries about prior med-
ications post-diagnosis projects for the patient the contingent
possibility that a treatment recommendation is forthcoming;
and (ii) how the patient’s responding turn can either encou-
rage or discourage progressivity, inevitably shaping the
recommendation proper.
Data and method
The UK primary care data meeting the inclusion criteria for
the wider study (cf. Stivers & Barnes, 2017) were drawn from
two existing datasets of recorded consultations. Dataset 1 was
collected between 2004 and 2005 across two boroughs of a
large urban area in the South of England, yielding 506 audio-
recorded patient consultations with 13 primary care physi-
cians from five general practices (see Wheat, Barnes, & Byng,
2015). Dataset 2 was collected between 2014 and 2015 across a
large city in the West of England and its surrounding areas,
yielding 327 video-recorded patient consultations with 23
primary care physicians from 12 general practices (see
Jepson et al., 2017). Appropriate ethical approvals were
obtained from Local National Health Service Research Ethics
Committees.
In dataset 1, 263 randomly selected recordings were
screened resulting in 127 cases of physician-initiated recom-
mendations for new drug treatments. In dataset 2, all 327
consultations were screened, resulting in a further 266 cases.
For a total of 393 cases, additional coding for the presence or
the absence of pre-recommendation sequences1 was devel-
oped and applied. Note that 15% (n = 57) of cases featured
pre-sequences. In the extracts presented below, physician
enquiries are represented in boldface type, and treatment
recommendation turns are indicated by an arrow.
Analysis
Physician enquiries about prior medicines: Pre-diagnosis
Pre-sequences are not the only means for gathering infor-
mation about prior medication use. Patients often volun-
teer information about medicines they have already taken
or tried, and whether they have been effective whilst
establishing the reason for the visit. Additionally, in the
subsequent information-gathering phase, physicians often
ask patients for information about prior medication use.
In (7), the patient, who is new to the practice, has pre-
sented with unexplained pain down her right side. As part
of his information-gathering activity, the physician has
just asked if she is taking any regular medications and
then directs her to lie down on the examination couch.
Just prior to commencing his physical examination at line
1, he then asks, “Have you been taking >anything< for the
↑pain o:r_”. The information request is formatted as a
polar question, pushed towards a ‘no’ by the inclusion of
the negatively valenced item “anything” (Heritage,
Robinson, Elliott, Beckett, & Wilkes, 2007). However,
arguably the addition of the stretched turn-final “o:r”
(Lindström, 1997) mitigates that push. The patient’s
response first goes towards the apparently aimed-for
‘No’, and is subsequently reversed. She then extends and
qualifies her response across lines 3–6. This expanded
response allows the patient to assert her epistemic author-
ity and extend the terms of the question to name the OTC
medication she has tried, but also the fact that it was not
effective. The physician registers the response at line 7,
and at line 9 his “Okay” heralds a shift to begin a next
activity (Beach, 1995; Schegloff, 2007) – the physical
examination.
(7) 01010101
1 DOC: Have you been taking >anything< for
2 the ↑pain o:r_
3 PAT: No: (.) I <well yeah I tried to take
4 uh:m ibuprofen=>but it
5 didn’t go< anywhere near the
6 [pa:in,[so: uh:m_
7 DOC: [Noh_ [M:m
8 (1.0)
9 DOC: °O[kay.°
10 PAT: [°O::h Go:d aw::h° ((Getting up on
11 the examining couch))
12 (0.5)
13 PAT: [↑A(h)uh huh
14 DOC: [So >if yo:u< (.) ↑pop these legs down
15 the:re,
((180 lines not shown))
195DOC: I I c’n give you something something
196 a bit stronger than
197 ibuprofen if that’s::=
198PAT: =Ple:ase.
It is not until 180 lines later, after delivering an uncertain
diagnosis, and advising the patient to continue her exercise
routine, the physician recommends a prescription-only anti-
inflammatory medicine. At line 195, formulating an offer for,
“something a bit stronger than ibuprofen,” he displays an
orientation and sensitivity to the information solicited earlier
at lines 3–6, in particular the fact that the patient has tried an
1Whilst restricting the pre-s coding to cases fitting our original inclusion criteria enabled us to track any effect on the choice of recommending action and
patient uptake, it ruled out other contexts where pre-s were observed including cases where: (a) a block resulted in no recommendation being issued; (b)
the recommendations were for no change to a current regimen, dosage changes, or non-drug treatments; (c) contingent recommendations; and (d)
recommendations initiated by patients.
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OTC anti-inflammatory, ‘ibuprofen’, that she has found to be
ineffective (“it didn’t go< anywhere near the pa:in”).
Physician enquiries about prior medication use were com-
mon in the sample. Extract 7 illustrates how, when launched
pre-diagnosis, they are treated as self-contained adjacency
pairs, and not oriented to by physicians or patients as pre-
liminary to a treatment recommendation. However, as shown
above, physicians would sometimes display sensitivity to these
prior informings post-diagnosis in the design of later treat-
ment recommendations. Robinson (2003) has argued that the
structural organization of medical activity shapes physicians’
and patients’ communicative behavior. Both parties under-
stand that “doctors cannot effectively treat problems that
they have not yet diagnosed, and thus the activity of treatment
is contingent upon that of diagnosis” (p. 31).
Next it will be demonstrated how the overall structure of
the consultation provides a resource allowing physician
requests for information about prior medicines post-diagno-
sis to be heard as projecting a treatment recommendation.
The examples illustrate how patients were able to recognize
these enquiries as preliminary to a treatment recommenda-
tion and how physicians were able to navigate two of the
obstacles/preconditions to successfully prescribing described
previously: redundancy and efficacy. Later, two further
obstacles: aversion and the potential for harm will be
addressed.
Physician enquiries about prior medicines: Post-diagnosis
In this section, the focus is on how patients treat enquiries
about medication usage delivered post-diagnosis as prelimin-
ary to a treatment recommendation. Specifically, it is argued
that through the use of responses that either promote or
inhibit prescribing, patients not only answer the question,
but commonly provide additional information orienting to a
candidate treatment. Moreover, where minimal responses are
provided, physicians often pursue information that may
further inform a prescription decision.
Consider (8) where the patient presents with a torn
shoulder ligament from an injury sustained three months
ago, complaining of a persistent lack of mobility. The physi-
cian has just examined her and recommended that she has an
additional scan. His enquiry at line 2, “have you had any anti-
inflammatories,” is immediately recalibrated as “ =are you
taking ibuprofen >or anything like that_<”; the redesign shift-
ing its specificity (drug class to drug name) (Lerner, Bolden,
Mandelbaum, & Hepburn, 2012), lexicon (“had” to “take”),
grammatical aspect (“have you had” to “are you taking”), and
polarity (no- to a yes-preferring). The turn final or-phrase, “or
anything like that,” a catch-all device keeping response
options open (McCarthy & Carter, 2006).
(8) 05060501
1 DOC: The:: other thing that we need to do
2 (0.7) have you had any
3 anti-inflammatories=are you taking
4 ibuprofen
5 [ >oranythinglikethat_< ]
6 PAT: [((Head nod))(Jus)[ doesn’t ]
7 PAT: [((Head shake
8 touch it.
9 DOC: °Okay.° .Thh have we prescribed you
10 anything stronger_
11 PAT: ((Three lateral head shakes))
12 >DOC: .h I ↑wonder whether we should give
13 you some stronger anti-
14 [inflammatories. To try and settle
15 PAT: [ ((Nodding))
16 DOC: [down any inflammation that is
17 PAT: [ ((Nodding))
18 DOC: the:re, .thh u::hr (1.4) >the other
19 thing we c’d do w’d be to give
20 you some stronger< painkillers_
As suggested earlier, the location of this enquiry makes it
recognisably projective of an upcoming treatment recommenda-
tion contingent on the response to the enquiry. That the patient
hears the question as implicating future treatment is visible insofar
as she not only answers the question negatively but at line 6, asserts
something unasked for – the inefficacy of the medication. This
suggests that the patient understands the physician as asking about
anti-inflammatories as part of a decision process with respect to
treatment. The patient’s expanded ‘go-ahead’ response is regis-
tered as adequate by the physician at line 9 with “Okay,” but then a
follow-up enquiry is launched, “have we prescribed you anything
stronger.” This second preliminary continues to project that the
patient’s response will affect a prescribing decision. At line 11, the
patient denies this proposition with multiple lateral head shakes,
her non-vocal display (Goodwin, 1980) leaving the way clear for
the physician to tentatively propose some stronger anti-inflamma-
tories and painkillers. The formulation of the recommending turn
shaped by the prior responses.
In (9), again, the patient hears the information request as
implicating future treatment. This time an expanded clausal
response is provided (Thompson, Fox, & Couper-Kuhlen,
2015) volunteering detailed information about lack of efficacy
when that was beyond the agenda of the physician’s question.
The patient has presented with a sudden onset acute head-
ache. After taking a detailed history, the physician checks her
blood pressure and rules that out as a contributory factor.
Although there is some uncertainty around the aetiology of
the headache, it is clear that the most pressing need is symp-
tom relief. At line 1, he launches the pre-sequence with,
“What’ve you tried taking,” his enquiry presupposing that
the patient has already attempted self-medicating. Following
a delay, at line 3, the patient answers more than the question
(Stivers & Heritage, 2001), providing the name of an OTC
painkiller, but then expanding her turn to detail her regimen.
She ends with a complaint that despite her best efforts at pain
control, “nothing is ↑moving,” a clear ‘go-ahead’ for remedial
action.
(9) 0102401
1 DOC: What’ve you tried taking.
4 R. K. BARNES
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2 (0.6)
3 PAT: I’ve taken er Co-↑dyamol for=it,
4 I’ve taken (1.3) (for for this). I
5 ↑didn’t take, I took two this morning
6 when I got=up .hhh at six, I
7 took two at ten. I’ve taken four=
8 already_ it’s: nothing is ↑moving.
9 DOC: Co-dydramol.
10 PAT: Yes::.
11 (0.4)
12 DOC: °Okay.°
13 (3.1)
14 DOC: °°(T)uh (t)uh (t)uh tuh:::°°
15 (2.2) ((Begins typing))
16>DOC: ↑Okay I’ll give=you something
17 slightly stronger.
18 PAT: ↑Oka::y.
After reconfirming the drug name at line 9, the physician
acknowledges this information and following some considera-
tion delivers a tailored pronouncement at line 16 on pretty firm
grounds, i.e. knowing the patient is not averse to taking some-
thing for the pain, and that what she has taken has hitherto
been insufficient. Whilst the “Okay” preface indicates forward
movement (Beach, 1995), the location and design of the recom-
mending turn indexes the prior enquiry as having been pre-
liminary. Moreover, the formulation, “something slightly
stronger,” is clearly shaped by the patient’s prior response.
In (10), the patient is waiting to have a gallbladder opera-
tion. She has complained of constant pain that is making her
lifting duties as a full-time carer difficult. The physician
examines her and diagnoses that the source of her pain may
actually be musculoskeletal rather than from her gallbladder.
Contrastingly, in this example, it is the physician who raises
the issue of efficacy, suggesting that this was indeed part of
the agenda and her move towards building a responsive
treatment recommendation. At line 1, the physician launches
a No-preferring request for information, “Have you ↑tri:ed an:
y (0.5) other treatments_ local things: (1.0) ↓anti-inflamma-
tory things:”. As in (8), the increasing specificity, plus the
concurrent activity of scanning the on-screen medication
history, amplifies the action.
(10) 10170101
1 DOC: Have you ↑tri:ed an:y (0.5) other
2 treatments_
3 [ local things: (1.0)
4 [((Gestures towards abdomen))
5 ↓anti [inflammatory things:_
6 [((Leans towards screen))
7 (0.4)
8 PAT: What (0.5) I ↑did ‘av it in my back to
9 start [with=I was
10 DOC: [M:m
11PAT: using like a cream [y’know, anti-
12DOC: [↑M:m
13PAT: flamma[t’ry cream.
14DOC: [>Was that< helpful?
15 (0.6)
16 PAT: [ W’ll not ] really.
17 PAT: [((Lateral shake))]
18 =[No: it d(h) idn’t do a lot ↑to it_
19 DOC: [£Not particularly_£ .hhh (0.3)
20 °er° because you got the indigestion
21 history I think (0.3) giving
22 you <tablets:> that are anti-inflam
23 mat’ry we might just trigger off
24> more [indigestion.<So .hhh it’s
25 PAT: [((Head nod))
26 DOC: ↑prob’ly worth trying an anti-
27 DOC: inflammatory cream
28 [again on this area that’s so:re,
29 DOC: [((Gestures across abdomen))
30 PAT: [Ye:ah
31 PAT: [((Head nod))
32 DOC: an see if that reduces the pai:n.
At line 8, the patient responds with a ‘transformative
answer’, adjusting the agenda of the question to report self-
medicating with an anti-inflammatory cream but applied to
her back (Stivers & Hayashi, 2010). As in (8), the physician
launches a follow-up enquiry at line 14, this time concerning
efficacy. Following a negative response from the patient at line
16, prefatory talk ruling out anti-inflammatory tablets by
foregrounding the potential for harm at lines 20-24 gives
ground for the physician’s suggestion that the patient try the
cream again, but this time on her abdomen. Again, the place-
ment of the recommending turn post-diagnosis indexes the
prior request as having been preliminary, its formulation
shaped by the prior response.
So far it has been established that enquiries about prior
medicines done post-diagnosis can function as preliminary to
a base treatment recommendation. These pre-sequences pro-
vide information that can allow physicians to avoid prescrib-
ing medicines the patient may have already been taking, or
had tried and found to be ineffective (redundancy and effi-
cacy). Through the position of the physician’s enquiry, an
upcoming treatment recommendation can be, to some extent,
projected. The patient’s response foreshadows what problems
or obstacles, if any, the physician will need to consider. It is
thereby recognisably consequential for, and inevitably shapes,
how the base treatment recommendation proper is delivered.
As reviewed above, in everyday conversation, the way that
interactants respond to preliminaries typically shapes whether
or not the projected next action appears at all. In this context,
the same pattern might be expected: that physicians employ
preliminary sequences to avoid making recommendations
that will be resisted or even rejected. Yet this is not completely
in line with what was observed. Physicians do, as shown in
this section, formulate treatment recommendations in ways
that are sensitive to the patient’s responses to preliminary
enquiries. However, the next section documents that physi-
cians do not necessarily abandon their recommendations in
the face of potential resistance. How patients respond to
preliminaries to foreground obstacles such as aversion to
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medicines and concerns over potential for harm, and how
physicians use these responses to press on with a recommen-
dation will now be reviewed.
Avoiding resistance: Reported side effects and aversion to
medicines
Out of a total sample of 393 UK recommendations for new drug
treatments, only 15% (n = 57) of cases featured pre-sequences.
This distribution suggests that pre-sequences are being initiated
‘for cause’. Yet contrary to what studies of pre-sequences in every-
day conversation might predict, when pre-recommendations
receive a discouraging response from patients, the projected base
sequence was seldom abandoned. In this sample, when a pre-
sequence was present, it was virtually equally likely to receive an
initial block (52%) as a go-ahead (48%) response from patients,
suggesting that blocks do not canonically lead to an abandonment
of the base recommendation. In this section, it is argued that
physicians rely on pre-sequences not only to identify obstacles
to acceptance but also to inform their recommendation in order
to avoid resistance. Thus, pre-sequences are not only reflective of a
cautious entry into the recommendation, they are also resources
to achieve the completion of the recommendation sequence.
In (11) unlike the cases seen so far, the physician is asking
how the patient is getting on with a recently prescribed
medicine rather than screening for what the patient may
have tried at home, or may have been prescribed on a prior
occasion. The physician launches his enquiry at line 1 with a
WH-question “What are the pa:in” which is abandoned mid-
turn for a more constraining yes-preferred polar question
design, “Are the painkillers helping?” A 1.5 second delay
and the patient’s ‘well-preface’ at line 4 heralds an expanded
response aligned against the polarity of the question
(Heritage, 2015), indexing some difficulty in responding.
(11) 05061302
1 DOC: What are the pa:in_ <Are the
2 pain killers helping?
3 (1.5)
4 PAT: We:ll, the painkillers I stopped
5 taking, because they were causing
6 me so: many troubles in my stomach,
7 (0.3)
8 DOC: >Were the:y?<
9 PAT: >They were affectin’< eh I’m sure it
10 was the painkillers were
11 affecting my stomach?
12 (0.7)
13 DOC: ‘Kay.
14 PAT: U:hm (1.0) an they didn’t they
15 th- th- th- the few days I was
16 takin’ em, (.) they weren’t (.) they
17 weren’t doin’ anything at
18 ↑all.
19 DOC: °‘Kay.°
20 PAT: An she did sa:y if they don’t wo:rk
21 (0.3) [come ]straight back.
22 DOC: [Yeah.]
23>DOC: Yep_ .thh [So the other] thing we’ve
24 PAT: [( )]
25 DOC: got then is u:hm (1.7) so the
26 if they’re upsetting you so that you
27 can’t take them .hh p’raps a
28 combination of taking jus some
29 paracetamol (.) an then you could
30 either ha:ve .hh a gel to rub in to
31 your back?
32 PAT: Yeah.
33 (0.4)
34 DOC: An if you’re getting ne:rve pains or
35 shooting pains
36 [down your legs: .hh] the::n .h we
37 PAT: [Tha:s that’s yeah ]
38 DOC: could ↑think about giving
39 you:: (1.3) a medication that helps
40 with (.) the ne:rve sens[ation.
41 PAT: [Yeah.
Across lines 9–11 and 14–18, the patient presents two
obstacles: side effects, “they were causing me so: many trou-
bles in my stomach”; and inefficacy, “the few days I was takin’
em, (.) they weren’t (.) they weren’t doin’ anything at ↑all.’
The responses clearly foreshadow the need for a different
treatment plan. However, still working on prescribing a pain-
killer, at lines 23–31, the physician duly takes into considera-
tion the patient’s response by proposing that he uses
Paracetamol (a simple analgesic) and anti-inflammatory gel
(containing a lower dose of the same painkiller). So this is
responsive, on the one hand, but persistent, on the other
hand. The prefatory inferential “so”, plus “the other thing
we’ve got then” are, respectively, backward and forward look-
ing, indexing that the recommending turn is contingent on
the prior, neatly circumventing the obstacles described and
progressing to sequence completion.
A second illustration of how physicians balance respon-
siveness to preliminary enquiries whilst side-stepping patient
resistance is shown in Extract 12. The physician has just
examined the patient’s hands and diagnosed a form of
arthritic disease. In line 1, the physician launches a pre-
sequence with her enquiry, “Have ↑you ↑TRIED any pain-
kille:rs > or anti-inflammatories > so: fa::r,” a polar question
that gets a well-prefaced response at line 4 from the patient,
foregrounding its non-straightforwardness (Schegloff &
Lerner, 2009): “(We:ll) to be honest I do:n’t really take table:
ts.” At line 19, the patient goes on to express some doubt over
the effectiveness of OTC medicines.
(12) 11191001
1 DOC: E:::HM ↑Have ↑ you ↑ TRIED any pain
2 kille:rs >or anti-inflammatories<
3 so:fa::r,=
4 PAT: =(We:ll) to be honest I do:n’t really
5 take table:ts,
((13 lines not shown))
19 PAT: They reckon that all medicine’s the
20 ↑sa::me according to that
21 medical doc↑tor? On the telly? You
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22 medical doc↑tor? On the telly? You
23 You see ↑i::t?
24 DOC: [I didn’t, no:, ↑I ↑mean ↑not a:ll
25 PAT: [(According,)
26 DOC: medicines aren’t
27 DOC: the [sa:me so, Huh
28 PAT: [I MEA:N over the counter medi
29 PAT: [cines.
30 DOC: [Oh yea:h,
31 PAT: Yeah.
32>DOC: Well I ↑think when it comes to over
33 the counter medicines for
34 THI::S:: I think you should try some
35 i:buprofe:n unless you have
36 >any problems< with it. If you’d
37 RATHER not[take it as a-
38 PAT: [As long as there’s
39 co-not co:deine because I don’t like
40 [codeine (makes me feel sick).
41 DOC: [.Tck No: >it’s got no codeine in
42 it<. So I:buprofen on its OW::n. .Hh
43 So you can EI:ther take it as
44 a ta:blet or if you don’t want to do
45 that you c’d use it as a GE::L
46 to rub in your ha::nds.
47 (0.4)
48 DOC: I wou:ld [like to do some-
49 PAT: [I ↑hav::e got some gel at
50 ↑h:ome [(°I think°),
51 DOC: [Have YOU::, [Okay,
52 PAT: [↓Yea:::h,-
Critical in this case is that the physician makes use of the
patient’s response to overcome her general aversion to taking
medicines and persist with a recommendation arguing that
the only legitimate reason for not taking it would be “pro-
blems” with it. At line 32, the physician’s well-prefaced
recommendation pushes back with an opposing ‘my side’
perspectival shift (Heritage, 2015), “I think you should try
some i:buprofe:n unless you have >any problems< with it”,
indirectly reducing the status of aversion as an obstacle to
care compared to medical “problems” such as side effects or
contraindications. At line 36 she orients to the patient’s
reported aversion, “If you’d RATHER not take it as a,” and
at line 45 puts forward an alternative, “you c’d use it as a
GE::L to rub in your ha::nds,” however the patient ultimately
resists the alternative recommendation on the grounds of
redundancy.
Patient aversion to medicines also included negative per-
sonal experiences with specific drugs. In (13), the first anni-
versary of the suicide of a close family member along with
other stressful life events has prompted a period of upset for
the patient. Amongst other information gathering, the physi-
cian has established that she is not taking any medications
currently. At line 1, she launches a pre-sequence, inviting the
patient’s perspective, “I just wonder what you thought about
sort’ov an antidepressant medication.” As talk about
treatment is already underway, this preliminary ‘feeling out’
proffers the candidate prescription, whilst avoiding moving
straight to a recommendation ‘proper’. It is immediately met
with a 1 second gap followed by a hedged response at line 5
indicating trouble in responding, ‘It depends what it is’.
(13) 06090703
1 DOC: An I just wonder about what you thought
2 about sort’ov an
3 antidepressant medication.
4 (1.0)
5 PAT: .Hhh It depe:nds what it is.
6 Uh I’ve had antidepressants before.
7 (0.6) I’ve has uh:m .snhh the only
8 ones I won’t take (0.6) I think
9 (0.5) it’s: Se:rtrali:ne.
10 DOC: Ri:ght.
11 PAT: I think. (0.6) I can’t remember
12 PAT: be cos’ thas the ones I took (.)
13 an overdose with. .Hh an I refu::se to
14 take ‘em again.
((10 lines not shown))
25 DOC: Did you (.) did it ↑help be↑fore
26 obviously you took the
27 o(h)verdose so you weren’t feeling
28 that great [on it< but .hhh did
29 PAT: [Uhuh_
30 DOC: it help you at=a::ll
31 [o:r h- how long had=you
32 PAT: [((Lateral head shake))
33 PAT: N:o? I’ve had (0.4)
34 think three or four lots of .hh anti
35 depressants. An not one ‘as (.)
36 I could say (0.6) has helped me. >or
37 not< kind ‘ov_
38 DOC: Ri:ght. .hh >an the other thing is
39 that they never help (.) well
40 not never but .h
41 PAT: ((Coughs))
42 DOC: with depression symptoms (0.5)
43 they’re less likely to help on their
44 own aren’t they. [You have to sort’ov
45 PAT: [Yeah.
46 DOC: do the different things
47>DOC: alongside an=.Hh uhm I m’n (.) we
48 could try another one if you
49 like,
50 PAT: I m’n I don’t mind_
51 DOC: U:hm .tk
52 PAT: giving one a g:o.
The patient expands her response expressing aversion to
one particular antidepressant – Sertraline – stemming from a
previous suicide attempt. At line 25, the physician enquires
about efficacy, and at lines 32–37, the patient responds with a
turn-initial lateral head shake, expanding her turn to inform
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the physician that she has tried three or four different anti-
depressants and none of them has helped. The physician
counters this at line 38, by adding a caveat post hoc, that
anti-depressants are less likely to help on their own. She
extends a cautious proposal at line 47 for a different antide-
pressant, “we could try another one if you like” which the
patient reluctantly accepts across lines 50 and 52, “I don’t
mind giving one a g:o.” In a similar manner to (11) and (12),
the physician uses the patient’s response as a resource, this
time to overcome her aversion to antidepressants, to persist
with a treatment recommendation.
Recall that in over half the sample, the use of pre-
sequences resulted in the delivery of a drug treatment recom-
mendation even in cases with no clear ‘go-ahead’ response. It
has been demonstrated that physicians were able to circum-
vent potential obstacles to care by adjusting recommendations
to be overtly oriented and sensitive to patients’ circumstances.
However, progression to a treatment recommendation in the
face of patient resistance was not always accomplished. Two
final examples will now be shown where although patient
resistance to a candidate treatment is ‘successful’, in that a
here-and-now recommendation is not made, instead of aban-
doning the projected action, physicians persist by exploiting
the ‘would-have-been’ recommendation slot to recommend
trying the medication in the future.
In (14), the patient presents with a flare up of a chronic
skin condition. She is going to be a bridesmaid in a few
weeks time. Another physician at the practice has pre-
viously prescribed a course of antibiotics that has not
been effective. There is a further difficulty in that the
patient has an on-going digestive condition that has been
exacerbated by this treatment. The physician has just sug-
gested that she could try a different antibiotic, but admits
the possibility of similar side effects. The alternative option
presented, ‘a pill’, refers to the oral contraceptive pill, which
is known to improve skin conditions. At line 1, the physi-
cian begins to recommend as yet unnamed treatment, “The
other thing you ↑can tr::y”, a suggestion that is abandoned
mid turn. The turn-in-progress is replaced by a pre-
sequence launched with a ‘No’-preferring, ‘have you ever
had a pi:ll_,’ then following a gap at line 3, recycled as a
‘Yes’-preferring, ‘are you on a pill’.
(14) 01111202
1 DOC: The other thing you ↑can tr::y, (.)
2 have you ever had a pi:ll_
3 (0.4)
4 DOC: Are you on a pill.
5 PAT: ↑U:hm I have had ↑a: lo:::ng long time
6 ago_ .hh But >I don’t really
7 wanna try that at the moment_<
8 DOC [>Okay_ cos that’s< the other
9 [( )
10 DOC: op[tion,
11 PAT: [it’s the:: (.) >thing about
12 putting on weight a:n y’know I can
13 just about get in my dre:ss
14 >as it is now.< S(h)::o,
15 DOC: £O[ka:y.£ SO
16 PAT: [^(H)UH
17 DOC: [>MAYBE ONCE THAT’S OVER,<
18 PAT: [(I JUS) DON’T HAVE AN OPTION to put
on any weight
At line 5, the patient’s turn-initial “↑Uhm” suggests the dis-
aligning nature (Schegloff, 2010) of her upcoming response – a
non-type-conforming repetitional answer (Heritage &
Raymond, 2012; Raymond, 2003) that is framed as responsive
to the question at line 1. In responding she informs the physician
that she has previously been on a pill “↑a: lo:::ng long time ago”,
recognising the request as preliminary to a projected possible
prescribing of the pill. Between lines 5 and 7, she mobilises both
her experiential knowledge and deontic authority extending her
turn to block the projected recommendation, “But I don’t really
wanna try that at the moment.”At line 8, the physician confirms
the would-have-been recommendation, “>Okay_ cos that’s< the
other option,” tying back to the action interrupted at the begin-
ning of line 1. Following the patient’s post-positioned account
between lines 11 and 14 regarding the fit of her bridesmaid’s
dress, instead of moving to a next activity; at line 15, the physi-
cian initiates an anticipatory recommendation overtly orienting
back to the patient’s account, “SO MAYBE ONCE THAT’S
OVER.”
In (15), the patient has requested a ‘fit note’ as medical
evidence for an extension to submitting her postgraduate
dissertation. The physician discovers that she has an estab-
lished history of anxiety and depression, is not on any med-
ication currently but is on a waiting list for psychological
therapy. At line 1, the physician launches a pre-sequence
enquiring about a particular class of medicines – antidepres-
sants – via a ‘No’-preferring polar question, “have you tried
antidepressants in the past at ↑a:ll?”
(15) 02011300
1 DOC: .hh An have you tried antidepressants
2 in the past at ↑a:ll?
3 PAT: I ha:ve. But a:: not helpfu:l.
4 >DOC: °Yeah.° ↑That’s fi:ne. .hh But just
5 (.) jus so you know they
6 [↓are ↓there if you wanted to try
7 PAT: [((Head nod))]
8 DOC: the:m.
At line 3, the patient offers a repetitional answer drawing
upon the framing of the prior question, “I ha:ve”, stepping
outside of its constraints by disconfirming its propositional
content. As in (14), she then extends her turn mobilising her
experiential knowledge to raise lack of efficacy as an obstacle
to the projected transition to the base treatment recommen-
dation sequence. At line 4, after registering the acceptability of
the patient’s response with “↑That’s fi:ne,” as in (14), the
physician pushes back to issue an anticipatory offer in place
of the would-have-been recommendation, “But just (.) so you
know they ↓are ↓there if you wanted to try the:m.”
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In this section, it has been argued that preliminaries are not
only used to identify medicines that are not ‘right’ for patients,
they are also resources for ascertaining the basis of possible
resistance, allowing physicians to push forward with a
projected recommendation. The question becomes: Do preli-
minary sequences lead to increased rates of patient resistance –
after all if physicians anticipate possible resistance and enquire
about medicines in these contexts, resistance might be more
likely – or decreased rates of patient resistance – because
physicians have shaped their recommendations to counter
any resistance, despite the fact that they may be persisting to
some extent against patient preferences? The next section
returns to the coding to explore this question.
The role of preliminaries in patient resistance to
recommendations
Preliminary sequences are not used equally often across all
prescribing contexts. They were more likely to
be used to recommend pain medications (including non-ster-
oidal anti-inflammatories) than other medication classes [χ2
(1, N = 121) = 20.1, p < 0.001], and slightly more likely to be
used when recommending treatment for patients with existing
rather than new conditions [χ2 (1, N = 172) = 4.1, p < 0.05].
Both of these contexts are ones where higher rates of resis-
tance might be reasonably anticipated since pain medications
often have side effects, and patients with on-going conditions
may be tired of taking medicines or have tried many medi-
cines already.
Moreover, it might be expected that pre-recommendation
sequencesmight constrain the type of action used to recommend
the medicine ultimately (Stivers et al., 2017). It is known that
proposals are mostly employed in contexts where there was
either diagnostic and/or treatment uncertainty, and that they
tend to be delivered in the spirit of trial and error (cf. Stivers
et al., 2017). For this very reason proposals rely on a collaborative
crafting with patients. Thus, it might be expected that pre-
sequences would be associated with proposals. Indeed, as
shown in Table 1, while pre-sequences led to the full range of
recommending actions, they were more likely to be followed by
proposals than other actions (23% vs 13%) [χ2 (1, N = 64) = 4.9,
p < 0.05], and were significantly less likely to be followed by
pronouncements than other actions (9% vs 17%) [χ2 (1,
N = 113) = 4.1, p < 0.05].
Finally, as raised earlier, if physicians anticipate possible
resistance and enquire about medicines in these contexts,
resistance might be more likely. Yet, if pre-sequences allow
physicians space to ease patients towards a recommendation
adjusted to accommodate patients’ obstacles to care, then it
follows that this practice should help avoid patient resistance
to the recommendation proper. Indeed bivariately, when a
pre-sequence was employed, the recommendation was signif-
icantly less likely to be resisted (including no response and
active resistance) than when the recommendation was offered
without a pre-sequence [χ2 (1, N = 337) = 17.4, p < 0.01].
The question then becomes whether resistance was less
likely to occur following a recommendation that had been
preceded by a pre-sequence, independent of other factors
including the action of the recommendation, medication
type, and whether the recommendation was for an acute or
chronic condition (see Table 2).
Table 2 shows that pre-recommendations were associated
with significantly less resistance not only bivariately, but inde-
pendent of the recommendating action, the medication being
recommended, and the type of patient problem being treated.
Considering the social costs of pushing ahead in the face of
resistance, the number of cases in our sample that transi-
tioned successfully from pre-recommendation sequence to
the base treatment recommendation in the face of obstacles
raised by patients was surprising. Why this might be so
deserves consideration. It should be borne in mind that
patients generally visit their primary care physician because
they require some kind of remedial action. Moreover, it
should also be considered that for both physicians and
patients, what counts as an acceptable remedial action is
often a medical one – consultations with no treatment recom-
mendations appear to be uncommon,2 and recommendations
for no action are rare.3 It might be also argued that physicians
have a tendency towards action rather than inaction, a ‘com-
mission bias’ (Croskerry, 2003) as it were, towards persuading
patients around obstacles to care in the service of treatment.
Yet the use of the pre-sequence also allows for patients to be
involved in the making of these decisions. One factor that may
well be associated with post hoc resistance tomedicines is a lack of
patient involvement in decision making. If there are obstacles to
treatment that have not been volunteered by patients or solicited
by physicians pre-diagnosis, use of pre-sequences post-diagnosis
can successfully elicit these in advance of the recommendation
proper. As seen earlier, patients often answer more than the
question, allowing physicians to ascertain the basis of a patient’s
possible resistance. It was also seen that because physicians are
able to build their recommendations in ways that display their
responsiveness to the patient’s answers to preliminary enquiries,
this allows them to persist with these recommendations and push
through to ‘successful’ sequence completion.
Table 1. Distribution of pre-sequences across recommending actions.
n % TOTAL
Pronouncements 10 9% 113
Suggestions 13 14% 94
Proposals 15 23% 64
Offers 10 17% 58
Assertions 9 14% 64
Table 2. Predictors of resistance to a treatment recommendation.
EST 95% CI
Pre-recommendation −.76 −1.49, −.03
Pronouncement recommendation −.19 −.76, .38
Proposal recommendation .48 −.16, 1.13
Psychiatric medication class .67 −.05, 1.39
Pain medication class −.18 −.73, .38
Chronic problem .55 −.09, 1.19
245/327 (14%) consultations in dataset 2 contained no recommendations at all, for any kind of treatment.
3Only 16/631 (2.5%) of all treatment recommendation types in dataset 2 were recommendations for no action.
HEALTH COMMUNICATION 9
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 B
ris
tol
] a
t 0
7:4
5 1
5 N
ov
em
be
r 2
01
7 
Discussion
Conversation analytic work to date has identified a range of
‘type-specific’ pre-sequences that project and are preliminary to
a base adjacency pair, including pre-announcements, pre-invi-
tations, pre-requests, and pre-offers (Heritage, 1984; Levinson,
1983; Schegloff, 1980, 2007; Terasaki, 2004). What they claim to
have in common is that they are designed to ‘test the waters’
(Clayman, 2002) – to anticipate and avoid a dispreferrred out-
come (e.g. already-known-ness, declines due to lack of avail-
ability, and denials or rejections due to other circumstantial
factors). In everyday conversation, a discouraging response to
a pre-sequence might be expected to result in the abandoning or
radical adjustment of the projected next action. However, in the
context of UK primary care, recommendations that were pre-
ceded by a pre-sequences were equally likely to be met with a
block or a go ahead response suggesting that patient response
was not criterial to proceeding to the base recommendation.
Pre-sequences are one way in which shared decision making
about medical treatments can be initiated by physicians. As has
been shown, it may not always be the case that patients treat the
possibility of being recommended a named medication or class
of medications as ‘right’ – necessary, beneficial or in accord with
their own preferences and concerns. For physicians, pre-
sequences are ‘cautious ways of proceeding’ (Sacks, 1992, p.
691), in that they can work to elicit any obstacles towards the
acceptance of a projected action upfront. Compared to recom-
mendations issued without pre-sequences, the presence of a pre-
recommendation did reduce the chance of patient resistance. It
seems, then, that the foreshadowing of the likely patient response
allowed physicians to adjust the base recommendation in such a
way as to minimize the potential for an ill-fitted recommendation
that might be resisted or rejected as unwanted or unnecessary.
At the same time, the employment of pre-sequences can also
serve patients’ interest. Because they are typically heard in ordin-
ary conversation as actions that are leading up to something else,
when done post-diagnosis – a place where patients might expect
to be involved in a decision about treatment – a pre-sequence
provides the patient with resources for ‘action ascription’ –
recognising what kind of next action is being projected
(Levinson, 2012). In other words, they offer an early space for
patients to exercise their epistemic and deontic authority to
encourage, discourage, or block a projected treatment recom-
mendation. The use of pre-sequences in the prescribing context
can therefore be a vehicle for shared decision making, allowing
patients and physicians a chance to discuss and negotiate opti-
mal treatment plans together, enhancing mutual participation.
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